Browsing Faculty of Health Sciences (FHS) by Author "Jalalian-Lechak, Zahra"
Now showing items 1-3 of 3
-
Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment
Graham, Susan M.; Masese, Linnet; Gitau, Ruth; Jalalian-Lechak, Zahra; Richardson, Barbra A.; Peshu, Norbert; Mandaliya, Kishor; Kiarie, James N.; Jaoko Walter G.; Ndinya-Achola, JO; Overbaugh, Julie; McClelland, R. Scott (2010)Persistent genital human immunodeficiency virus type 1 (HIV-1) shedding among women receiving antiretroviral therapy (ART) may present a transmission risk. We investigated the associations between genital HIV-1 ... -
Antiretroviral Adherence and Development of Drug Resistance Are the Strongest Predictors of Genital HIV-1 Shedding among Women Initiating Treatment
Graham, Susan M; Masese, Linnet; Gitau, Ruth; Jalalian-Lechak, Zahra; Richardson, Barbra A; Peshu, Norbert; Mandaliya, Kishor; Kiarie, James N; Jaoko, Walter; Ndinya-Achola, Jeckoniah; Overbaugh, Julie; McClelland, R Scott (University of Nairobi, 2010)Persistent genital human immunodeficiency virus type 1 (HIV-1) shedding among women receiving antiretroviral therapy (ART) may present a transmission risk. We investigated the associations between genital HIV-1 suppression ... -
The Breadth and Potency of Passively Acquired Human Immunodeficiency Virus Type 1-Specific Neutralizing Antibodies Do Not Correlate with the Risk of Infant Infection[down-pointing small open triangle]
Lynch, John B; Nduati, RW; Blish, Catherine A; Richardson, Barbra A; Mabuka, Jennifer M; Jalalian-Lechak, Zahra; John-Stewart, Grace; Overbaugh, Julie (Department of Pediatrics, 2011)Although a major goal of human immunodeficiency virus type 1 (HIV-1) vaccine efforts is to elicit broad and potent neutralizing antibodies (NAbs), there are no data that directly demonstrate a role for such NAbs in protection ...